Skip to main content

Remote Job Finders (RJF)

Fulcrum tanks as cancer concerns stymie sickle cell asset, trigger business reorg

Fulcrum Therapeutics’ is down more than 50% Tuesday morning as the biotech discontinues development of its lead asset. Ipsen’s Tazverik, which belongs to the same class, was pulled from the market in March due to the risk of secondary malignancies.

17 companies expected to create 400+ Massachusetts jobs add under 50

Seventeen life sciences businesses awarded Massachusetts tax incentives to add and retain 426 combined jobs hit 10% of that target as of Dec. 31. Three companies, including Novartis, had reported layoffs either last year or this year.

Moderna partners with CEPI on Ebola vaccine efforts amid outbreak in Africa

Riding a newfound surge of interest on infectious disease concerns, Moderna is linking up with a global vaccine foundation in hopes of developing a vaccine to slow the new surge in Ebola underway in the Congo and Uganda.
Scroll to top